转移
丹参
巨噬细胞移动抑制因子
癌症研究
癌症
体内
化学
磷酸化
医学
生物标志物
癌细胞
转录因子
激酶
体外
表面等离子共振
生物
药理学
植物医学
基质
信号转导
肿瘤坏死因子α
预酸化
作者
Chuhang Wang,Xiaochen Ni,Yuyan PAN,Wei Fan,Jianing Guo,Kaiyuan Zhang,Mingsi Zhang,Linfeng Zheng,Yunhai Wei,Tao Jiang,Guangji Zhang
摘要
Salvia miltiorrhiza Bunge has been a commonly used medicinal herb in China since ancient times, widely employed to treat blood stasis-related disorders, including cardiovascular and inflammatory diseases. Dihydrotanshinone I (DHT), a lipophilic diterpenoid derived from its roots, has demonstrated anti-tumor potential; however, its specific molecular mechanisms involved in gastric cancer (GC) metastasis remain a mystery. Here, we report that DHT significantly suppresses the invasion and metastasis of GC by directly targeting macrophage migration inhibitory factor (MIF). Using limited proteolysis-mass spectrometry (LiP-MS), we identified MIF as a direct binding target of DHT, which was further validated by surface plasmon resonance and molecular docking. Mechanistically, DHT binding to MIF restored GSK-3β activity, promoted β-catenin phosphorylation (Ser33/37/Thr41), and facilitated its proteasomal degradation, thereby inhibiting β-catenin nuclear translocation and transcription of epithelial-mesenchymal transition-related genes. In vivo experiments confirmed that DHT markedly suppressed peritoneal metastasis of GC. These findings not only elucidate a novel molecular axis-DHT/MIF/GSK-3β/β-catenin-in suppressing GC metastasis but also provide a mechanistic basis for the ethnopharmacological application of Danshen in cancer-related disorders. Furthermore, our findings raise the hypothesis that MIF might serve as a potential predictive biomarker for DHT treatment response in GC, a concept that warrants future clinical validation.
科研通智能强力驱动
Strongly Powered by AbleSci AI